Researchers analyzed breathlessness, cough data and sputum cultures for several cohorts of COPD patients every day for two weeks. At the end of the data collection period, they found the sickest patients were also the ones with higher bacteria counts — of Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumonae and Pseudomonas aeruginosa — in the lungs. COPD damages the lungs’ ability to defend against bacteria, according to a Futurity analysis of the study.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Researchers suggested therapy targeted at reducing bacterial counts in COPD patients’ lungs could reduce daily symptoms and improve quality of life for patients with the condition.
More Articles on Quality:
9 Statistics on the State of Infection Prevention in NHSN Hospital ICUs
5 Infection Control Storires From PDI
Study: Patient Experience Doesn’t Predict Outcomes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.